Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thrombotic Thrombocytopenic Purpura, Acquired”

Showing 10 of 0 results

Not applicableLooking for participantsNCT06945861
What this trial is testing

Immunological Aspect of Thrombotic Thrombocytopenic Purpura (TTP)

Who this might be right for
Thrombotic Thrombocytopenic Purpura (TTP)
University Hospital, Rouen 44
Large-scale testing (Phase 3)Ended earlyNCT00799773
What this trial is testing

Evaluating the Effectiveness of Adding Rituximab to Standard Treatment for Thrombotic Thrombocytopenic Purpura (TTP)

Who this might be right for
Thrombotic Thrombocytopenic Purpura
Carelon Research 3
Large-scale testing (Phase 3)Ended earlyNCT00411801
What this trial is testing

Safety and Efficacy Study to Compare Uniplas With Cryosupernatant Plasma in Thrombotic Thrombocytopenic Purpura (TTP)

Who this might be right for
Thrombotic Thrombocytopenic Purpura (TTP)
Octapharma 8
Post-approval studies (Phase 4)UnknownNCT05135442
What this trial is testing

Efficacy and Safety of Bortezomib as First-line Treatment of Acquired TTP

Who this might be right for
Thrombotic Thrombocytopenic Purpura, Acquired
Peking Union Medical College Hospital 30
Large-scale testing (Phase 3)Study completedNCT03393975
What this trial is testing

BAX 930 in Children, Teenagers, and Adults Born With Thrombotic Thrombocytopenic Purpura (TTP)

Who this might be right for
Thrombotic Thrombocytopenic Purpura (TTP)
Baxalta now part of Shire 52
Large-scale testing (Phase 3)Study completedNCT05468320
What this trial is testing

Caplacizumab and Immunosuppressive Therapy Without Firstline Therapeutic Plasma Exchange in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura

Who this might be right for
Thrombotic Thrombocytopenic Purpura
Sanofi 51
Testing effectiveness (Phase 2)Study completedNCT01151423
What this trial is testing

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor (vWF) Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

Who this might be right for
Acquired Thrombotic Thrombocytopenic Purpura
Ablynx, a Sanofi company 75
Testing effectiveness (Phase 2)Ended earlyNCT00726544
What this trial is testing

Clinical Outcome Study of ARC1779 Injection in Patients With Thrombotic Microangiopathy

Who this might be right for
Thrombotic MicroangiopathyThrombotic Thrombocytopenic Purpura
Archemix Corp. 100
Not applicableWithdrawnNCT02626663
What this trial is testing

The Role of Microparticles as a Biomarker

Who this might be right for
Atypical Hemolytic Uremic SyndromeThrombotic Thrombocytopenic PurpuraMicroparticles+1 more
University of Rochester
Not applicableUnknownNCT05785468
What this trial is testing

A Retrospective, Observational Study on the Response to Caplacizumab Treatment in aTTP Patients: the Italian Experience (ROSCAPLI)

Who this might be right for
Thrombotic Thrombocytopenic Purpura
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 1

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation